Jennifer Nast

Jennifer Nast is an accomplished professional in the pharmaceutical industry, currently serving as Senior Director of Global Oncology Value, Access & Pricing at Daiichi Sankyo, Inc. since September 2022. Previously, Jennifer held several key positions at Novartis, including Director of Early Pipeline Strategy & BD&L/M&A and Director of Global Strategic Pricing & Access in the hematology sector. Prior to Novartis, roles included Director of Global Pricing at AstraZeneca and various positions at Bristol-Myers Squibb, where responsibilities spanned global pricing, market access, and finance. Jennifer holds an MBA in Finance & Marketing from The Wharton School and a Bachelor of Science in Finance from West Virginia University.